Hypogonadism, Male Clinical Trials

9 recruiting

Hypogonadism, Male Trials at a Glance

9 actively recruiting trials for hypogonadism, male are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Boston, Seattle, and St Louis. Lead sponsors running hypogonadism, male studies include Seattle Institute for Biomedical and Clinical Research, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Brigham and Women's Hospital.

Browse hypogonadism, male trials by phase

Treatments under study

About Hypogonadism, Male Clinical Trials

Looking for clinical trials for Hypogonadism, Male? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hypogonadism, Male trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hypogonadism, Male clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

Testosterone Treatment in Men With Chronic Kidney Disease

Hypogonadism, MaleKidney Disease, Chronic
St. Louis University20 enrolled1 locationNCT05249634
Recruiting
Phase 2

Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism

PainOpioid UseHypogonadism, Male
Brigham and Women's Hospital150 enrolled1 locationNCT04798469
Recruiting
Phase 2

Improving Cancer-related Fatigue, Sexual Dysfunction and Quality of Life in Older Men With Cancer and Androgen Deficiency

CancerFatigueHypogonadism, Male
Seattle Institute for Biomedical and Clinical Research230 enrolled3 locationsNCT04301765
Recruiting
Phase 3

52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

Hypogonadism, Male
Halozyme Therapeutics100 enrolled20 locationsNCT06689085
Recruiting
Not Applicable

EndoPAT Device for Endothelial Dysfunction in ED

Hypogonadism, MaleErectile DysfunctionEndothelial Dysfunction
University of California, Irvine120 enrolled1 locationNCT06720597
Recruiting

Fertility Enhancement Through Regenerative Treatment in Ovaries and Testes

Hypogonadism, MaleTestosterone DeficiencyGonadal Dysfunction+3 more
Jumeirah American Clinic60 enrolled1 locationNCT06841328
Recruiting
Phase 2

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Hypogonadism, MaleFatigue Syndrome, Chronic
Seattle Institute for Biomedical and Clinical Research240 enrolled2 locationsNCT04049331
Recruiting

ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer

NSCLC Stage IVSex DisorderHypogonadism, Male+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS80 enrolled1 locationNCT06532149
Recruiting
Phase 4

Effects of Testosterone Undecanoate vs Placebo on Intrahepatic Fat Content in Overweight/Obese Men With T2DM or Prediabetes and Hypogonadism

Hypogonadism, MaleFatty LiverOverweight/Obesity+1 more
Alexandra Kautzky-Willer32 enrolled1 locationNCT03851627